Rafael Díaz
Estudios Clínicos Latinoamérica(AR)Instituto Cardiovascular de Rosario(AR)Meander Medisch Centrum(NL)
Publications by Year
Research Areas
Lipoproteins and Cardiovascular Health, Antiplatelet Therapy and Cardiovascular Diseases, Heart Failure Treatment and Management, Health Systems, Economic Evaluations, Quality of Life, Acute Myocardial Infarction Research
Most-Cited Works
- → Dabigatran versus Warfarin in Patients with Atrial Fibrillation(2009)11,130 cited
- → Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome(2018)3,374 cited
- → Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial(2019)2,888 cited
- → Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction(2019)2,818 cited
- → Spironolactone for Heart Failure with Preserved Ejection Fraction(2014)2,661 cited
- → Apixaban in Patients with Atrial Fibrillation(2011)2,406 cited